Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:acquisitionYear |
2008
|
| gptkbp:focus |
infectious diseases
oncology |
| gptkbp:foundedYear |
1995
|
| gptkbp:headquartersLocation |
gptkb:Hayward,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kosan Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
Hsp90 inhibitors
epothilones |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:status |
defunct
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
KOSN
|
| gptkbp:bfsParent |
gptkb:Chaitan_Khosla
|
| gptkbp:bfsLayer |
8
|